Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular risks
Pharma
In a big win for generics drugmakers, SCOTUS sides with Hikma
The U.S. Supreme Court has sided with Hikma, ruling that its generic version of Amarin’s Vascepa does not infringe patents held by the Irish company.
Kevin Dunleavy
Jun 4, 2026 3:11pm
Lilly answers FDA's call for more Foundayo safety information
Apr 16, 2026 9:43am
Novo's Rybelsus gains FDA expansion to reduce risk of MACE
Oct 21, 2025 10:45am
Novo's oral GLP-1 Rybelsus cuts heart disease risks
Mar 31, 2025 11:30am
Silence Therapeutics gets loud in Lp(a) awareness campaign
Aug 29, 2024 8:30am
Novo Nordisk pulls Wegovy HF submission, will resubmit in 2025
Aug 7, 2024 10:30am
